0000000001289334

AUTHOR

Louiza Djaouti

showing 4 related works from this author

Liver carbohydrate and lipid metabolism of insulin-deficient mice is altered by trans-10, cis-12 conjugated linoleic acid.

2009

Feeding mice the trans-10, cis-12 (t10c12) conjugated linoleic acid (CLA) isomer is associated with lipodystrophy, insulin resistance, hyperinsulinemia, and liver steatosis. It has been hypothesized that CLA-induced liver steatosis is the result of increased hepatic lipogenesis stimulated by high insulin levels. We studied the effects of a 12-d t10c12CLA treatment (1 g/100 g diet) on liver carbohydrate and lipid metabolism in control and streptozotocin (STZ)-injected mice. STZ mice were characterized by insulin deficiency, hypertriglyceridemia, and depletion of liver triglyceride and glycogen. Remarkably, feeding t10c12CLA to diabetic mice (STZ-CLA) normalized these variables. Reconstitutio…

Malemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentMedicine (miscellaneous)BiologyDiabetes Mellitus Experimentalchemistry.chemical_compoundMiceInsulin resistanceInternal medicinemedicineAnimalsLinoleic Acids ConjugatedNutrition and DieteticsGlycogenGlucokinaseInsulinFatty livernutritional and metabolic diseasesLipid metabolismmedicine.diseaseLipid MetabolismMice Inbred C57BLEndocrinologychemistryGene Expression RegulationLiverGlycogenesisLipogenesisBody CompositionCarbohydrate Metabolismlipids (amino acids peptides and proteins)The Journal of nutrition
researchProduct

Different effects of pioglitazone and rosiglitazone on lipid metabolism in mouse cultured liver explants.

2010

Background Pioglitazone (PIO) and rosiglitazone (ROSI) are widely used as oral antidiabetic agents for treatment of type 2 diabetes. Although these medications exert similar effects on blood glucose, recent clinical studies indicated that PIO has a more pronounced beneficial effect on lipid parameters than ROSI. In order to get further insight into the lipid effects of both drugs, we tested whether PIO, compared to ROSI, could exert direct effects on lipid liver metabolism in relation with plasma lipids. Methods We performed in vitro studies using mice liver slices incubated 21 h either with ROSI (1 µmol/L) or PIO (7.5 µmol/L). Results We showed that both glitazones slightly reduced HMG-CoA…

medicine.medical_specialtyApolipoprotein BEndocrinology Diabetes and MetabolismRosiglitazoneTissue Culture Techniqueschemistry.chemical_compoundMiceEndocrinologyInternal medicineInternal MedicinemedicineAnimalsHumansScavenger receptorGlycated HemoglobinbiologyPioglitazoneCholesterolbusiness.industryCholesterol HDLLipid metabolismLipaseLipid MetabolismMice Inbred C57BLPPAR gammaEndocrinologychemistryLiverLipogenesisbiology.proteinThiazolidinedionesHepatic lipaseRosiglitazonebusinessPioglitazonemedicine.drugDiabetes/metabolism research and reviews
researchProduct

Regulation of lipid flux between liver and adipose tissue during transient hepatic steatosis in carnitine-depleted rats

2007

Rats with carnitine deficiency due to trimethylhydrazinium propionate (mildronate) administered at 80 mg/100 g body weight per day for 10 days developed liver steatosis only upon fasting. This study aimed to determine whether the transient steatosis resulted from triglyceride accumulation due to the amount of fatty acids preserved through impaired fatty acid oxidation and/or from up-regulation of lipid exchange between liver and adipose tissue. In liver, mildronate decreased the carnitine content by approximately 13-fold and, in fasted rats, lowered the palmitate oxidation rate by 50% in the perfused organ, increased 9-fold the triglyceride content, and doubled the hepatic very low density …

Malemedicine.medical_specialtyVery low-density lipoproteintissu adipeuxAdipose tissuerattus rattusBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicinestéatose hépatiqueCarnitineInternal medicinemedicineAnimalsLipolysisCarnitineRats Wistarpathologie animaleMolecular BiologyBeta oxidationlipide030304 developmental biologychemistry.chemical_classification0303 health sciencesTriglycerideFatty AcidsFatty acidCell Biologyfoiemedicine.diseaseLipidsRats[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry Molecular Biology/Biomolecules [q-bio.BM]Fatty LiverLipoproteins LDLLipoprotein LipaseEndocrinologyAdipose TissueGene Expression RegulationLiverchemistryHepatocytesRATSteatosisTriolein030217 neurology & neurosurgerymedicine.drug
researchProduct

Effects of modulation of body fat in production of adiponectin in mice : consequences on hepatic metabolism of lipids

2010

Adiponectin (ApN), a 30-kDa adipokine abundantly produced by adipose tissue has been described for the first time in 1995. Early findings demonstrating serum adiponectin levels are inversely correlated with obesity initiated intense investigation of the relationship between adiponectin and all symptoms of the metabolic syndrome. Of these studies, strong evidence suggests that a weight loss induced by medication or hypocaloric diet led to increased circulating ApN levels and improvement of biochemical parameters. Thus, high levels of ApN have been correlated with an improvement of insulin sensitivity and lipid parameters reducing cardiovascular risk. However mechanisms involved in the improv…

E-oxydation[SDV.SA] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyTissu adipeuxStreptozotocineNo english keywordsGlitazoneAdiponectineObésitéFoieExplantAcide linoléique conjuguéMétabolisme des lipides
researchProduct